A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

In Japan, clinical use is climbing faster, with about 4,500 people now on the drug. ARIA rates in Japan are half those in the U.S., which was also the case in the Phase 3 Clarity trial. Meanwhile, use ...

Feeling lonely increased risk for all-cause dementia by 31 percent and cognitive impairment by 15 percent. Loneliness is a ...

Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...

Alzheimer’s, dementia webinar More than 6 million individuals are living with Alzheimer’s disease in the U.S., and there are ...

In 2022, The Tulsa Opera partnered with a program called Songs By Heart that works to bring live, interactive, music therapy ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

In the last two years, two drugs have been federally approved to slow the onset of Alzheimer's disease in its early stages, ...

Residents from Erie and surrounding counties participated in this year’s Erie Shores Walk to End Alzheimer’s, raising a record-breaking $103,000 to support the care, support and research programs ...

News continues bringing awareness to Alzheimer’s and other dementias this week.7News’ Adrianna Hopkins has been sharing the ...